Doctor Michaela Meyer
Bayer AG, Wuppertal (Germany)
Leveraging translational approaches for accelerated clinical development of vericiguat
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Chronic heart failure e-posters
A concentration-QTc analysis of vericiguat
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Chronic heart failure e-posters
Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction
Event: Heart Failure 2019
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
ESC 365 is supported by
